WallStreetZenWallStreetZen

NASDAQ: BNTX
Biontech Se Earnings & Revenue

BNTX past earnings growth

How has BNTX's earnings growth performed historically?
Company
-89.58%
Industry
51.55%
Market
108.31%
BNTX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BNTX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BNTX past revenue growth

How has BNTX's revenue growth performed historically?
Company
-76.96%
Industry
159.68%
Market
18.26%
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BNTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BNTX earnings and revenue history

Current Revenue
$4.2B
Current Earnings
$1.0B
Current Profit Margin
24.4%

BNTX Return on Equity

Current Company
4.6%
Current Industry
-63.5%
Current Market
188%
BNTX's Return on Equity (4.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNTX announces earnings.

BNTX Return on Assets

Current Company
4.2%
Current Industry
2.9%
BNTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNTX Return on Capital Employed

Current Company
5.78%
Current Industry
19.5%
BNTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNTX$4.15B$1.51B$1.01B+96.02%+386.87%
GMAB$2.40BN/A$633.48M+39.38%+21.77%
ALNY$1.83B-$215.27M-$440.24M+89.45%N/A
ARGX$38.62M-$209.00M-$320.71M+9.84%N/A
RPRX$2.35B$1.32B$1.13B+5.58%+97.41%

BNTX earnings dates

Next earnings date
May 6, 2024

Biontech Se Earnings & Revenue FAQ

What were BNTX's earnings last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q4 2023 earnings per share (EPS) of $2.12, up 78.57% year over year. Total Biontech Se earnings for the quarter were $508.78 million. In the same quarter last year, Biontech Se's earnings per share (EPS) was $9.90.

If you're new to stock investing, here's how to buy Biontech Se stock.

What was BNTX's earnings growth in the past year?

As of Q2 2024, Biontech Se's earnings has grown -89.58% year over year. This is 141.12 percentage points lower than the US Biotechnology industry earnings growth rate of 51.55%. Biontech Se's earnings in the past year totalled $1.01 billion.

What is BNTX's earnings date?

Biontech Se's earnings date is Invalid Date. Add BNTX to your watchlist to be reminded of BNTX's next earnings announcement.

What was BNTX's revenue last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q4 2023 revenue of $1.64 billion up 63.89% year over year. In the same quarter last year, Biontech Se's revenue was $4.55 billion.

What was BNTX's revenue growth in the past year?

As of Q2 2024, Biontech Se's revenue has grown -76.96% year over year. This is 236.64 percentage points lower than the US Biotechnology industry revenue growth rate of 159.68%. Biontech Se's revenue in the past year totalled $4.15 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.